Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e909c815cd07f3b1cb3a780273fa1fea |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
filingDate |
1999-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fb1fa7f5f3a6a6a85b824272b47ebc2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1410898d331cd5c3b4f041fadaabc3d2 |
publicationDate |
2000-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
LV-12342-B |
titleOfInvention |
PROGESTERON FOR REDUCTION OR REDUCTION OF EXTRACTION |
abstract |
The present invention provides a method of treating or reducing ischemia or incidence of cardiovascular events by administering progesterone. Progesterone, unlike synthetic progestins, has been demonstrated to supplement, rather than to decrease, the beneficial effects of estrogen therapy on myocardial ischemia in females. |
priorityDate |
1996-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |